For US Healthcare Professionals Important Safety Information Full Prescribing Information
Linkedin Facebook Twitter

Control With Confidence

The only antivenom derived from native US pit vipers to treat envenomations from all species of North American pit vipers1

Linkedin Facebook Twitter

Strength and Speed When You Need It Most

North American pit vipers across the United States icon

Clinically Relevant

Derived from geographically and clinically relevant US snakes1,2

See Our
Venomics Approach
IgG antibody icon

Specifically Engineered

Designed with a spectrum of small, venom-specific protein (Fab) fragments1,3

View the MOA
Copperhead Level 1 evidence icon

Proven Efficacy

Halted all clinically important effects of envenomation, with Level 1 evidence specifically for copperhead envenomation1,4

Examine the Data

Antivenom for Rattlesnakes, Cottonmouths, and Copperheads

Dosing for Initial and Sustained Control of Envenomation

Administer CroFab as soon as possible to prevent clinical deterioration1

Review Dosing Recommendations

CroFab in Clinical Practice – Hear Real Patient Experiences

REFERENCES

1. CroFab® [prescribing Information]. BTG International Inc.; August 2018. 2. WHO Expert Committee on Biological Standardization. WHO Technical Report Series, No. 1004, Annex 5; 2017. Accessed September 10, 2021. https://www.who.int/biologicals/WHO_TRS_1004_web.pdf 3. Laustsen AH, María Gutiérrez J, Knudsen C, et al. Pros and cons of different therapeutic antibody formats for recombinant antivenom development. Toxicon. 2018;146:151-175. 4. Gerardo CJ, Quackenbush E, Lewis B, et al. The efficacy of Crotalidae polyvalent immune Fab (ovine) antivenom versus placebo plus optional rescue therapy on recovery from copperhead snake envenomation: a randomized, double-blind, placebo-controlled, clinical trial. Ann Emerg Med. 2017;70(2):233-244.